Literature DB >> 27297798

Adipose tissue microbiota in humans: an open issue.

A Zulian1,2, R Cancello1,2, E Cesana3, E Rizzi4, C Consolandi4, M Severgnini4, V Panizzo5, A M Di Blasio2, G Micheletto6, C Invitti1.   

Abstract

BACKGROUND: A specific 'adipose tissue' microbiota has been recently identified in mice and hypothesized in humans. The purpose of this study was to verify the presence of microbiota of human whole adipose tissue and isolated adipocytes by combining culture-dependent and independent methods.
METHODS: Standard microbiological cultural techniques and 16S ribosomal RNA (16S rRNA) gene sequencing (Illumina technology) on DNA and RNA were employed to study (a) whole abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) from 14 obese and five normal-weight subjects and (b) mature adipocytes isolated from SAT and VAT after collagenase digestion or mechanical separation. To optimize the 16S rRNA gene detection, we used different DNA extraction methods (lysis with proteinase K, proteinase K+lysozyme and microbeads) and amplification procedures (semi-quantitative standard PCR and real-time quantitative PCR).
RESULTS: Microbiological cultures were negative in all analyzed samples. In enzymatically isolated adipocytes, 90% of the sequenced bacterial DNA belonged to Clostridium histolyticum, the bacterium from which the collagenase enzyme was isolated. Bacterial 16S rRNA gene was not detected from DNA and RNA of whole SAT and VAT, as well as of mechanically isolated mature adipocytes, even after blocking with a specific primer the nonspecific amplification of human mitochondrial 12S rRNA.
CONCLUSIONS: Our results do not support the presence of a human adipose tissue microbiota. In addition, they emphasized the technical problems encountered when applying metagenomic studies to human tissues with very low or absent bacterial load.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27297798     DOI: 10.1038/ijo.2016.111

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  19 in total

1.  Salivary microbiota and metabolome associated with celiac disease.

Authors:  Ruggiero Francavilla; Danilo Ercolini; Maria Piccolo; Lucia Vannini; Sonya Siragusa; Francesca De Filippis; Ilaria De Pasquale; Raffaella Di Cagno; Michele Di Toma; Giorgia Gozzi; Diana I Serrazanetti; Maria De Angelis; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

Review 2.  Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.

Authors:  L Geurts; A M Neyrinck; N M Delzenne; C Knauf; P D Cani
Journal:  Benef Microbes       Date:  2014-03       Impact factor: 4.205

3.  Bacterial community variation in human body habitats across space and time.

Authors:  Elizabeth K Costello; Christian L Lauber; Micah Hamady; Noah Fierer; Jeffrey I Gordon; Rob Knight
Journal:  Science       Date:  2009-11-05       Impact factor: 47.728

4.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

Review 5.  Potential mechanisms for the emerging link between obesity and increased intestinal permeability.

Authors:  Tatiana F S Teixeira; Maria Carmen Collado; Célia L L F Ferreira; Josefina Bressan; Maria do Carmo G Peluzio
Journal:  Nutr Res       Date:  2012-09-07       Impact factor: 3.315

6.  Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions.

Authors:  Marcus J Claesson; Qiong Wang; Orla O'Sullivan; Rachel Greene-Diniz; James R Cole; R Paul Ross; Paul W O'Toole
Journal:  Nucleic Acids Res       Date:  2010-09-29       Impact factor: 16.971

7.  Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota.

Authors:  Matteo Serino; Elodie Luche; Sandra Gres; Audrey Baylac; Mathieu Bergé; Claire Cenac; Aurelie Waget; Pascale Klopp; Jason Iacovoni; Christophe Klopp; Jerome Mariette; Olivier Bouchez; Jerome Lluch; Francoise Ouarné; Pierre Monsan; Philippe Valet; Christine Roques; Jacques Amar; Anne Bouloumié; Vassilia Théodorou; Remy Burcelin
Journal:  Gut       Date:  2011-11-22       Impact factor: 23.059

8.  Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.

Authors:  Laurent Peyrin-Biroulet; Florent Gonzalez; Laurent Dubuquoy; Christel Rousseaux; Caroline Dubuquoy; Cécilia Decourcelle; Alain Saudemont; Mickael Tachon; Elodie Béclin; Marie-Françoise Odou; Christel Neut; Jean-Frédéric Colombel; Pierre Desreumaux
Journal:  Gut       Date:  2011-09-21       Impact factor: 23.059

9.  Dysbiosis of the gut microbiota in disease.

Authors:  Simon Carding; Kristin Verbeke; Daniel T Vipond; Bernard M Corfe; Lauren J Owen
Journal:  Microb Ecol Health Dis       Date:  2015-02-02

10.  The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline.

Authors:  Jérôme Lluch; Florence Servant; Sandrine Païssé; Carine Valle; Sophie Valière; Claire Kuchly; Gaëlle Vilchez; Cécile Donnadieu; Michael Courtney; Rémy Burcelin; Jacques Amar; Olivier Bouchez; Benjamin Lelouvier
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more
  8 in total

Review 1.  Role of the Gut Microbiome in Beta Cell and Adipose Tissue Crosstalk: A Review.

Authors:  José Ignacio Martínez-Montoro; Miguel Damas-Fuentes; José Carlos Fernández-García; Francisco J Tinahones
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-12       Impact factor: 6.055

Review 2.  Liver Steatosis: A Marker of Metabolic Risk in Children.

Authors:  Costanza Renata Neri; Serena Scapaticci; Francesco Chiarelli; Cosimo Giannini
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 3.  Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases.

Authors:  Lucas Massier; Matthias Blüher; Peter Kovacs; Rima M Chakaroun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-09       Impact factor: 5.555

4.  Microbiota in mesenteric adipose tissue from Crohn's disease promote colitis in mice.

Authors:  Zhen He; Jinjie Wu; Junli Gong; Jia Ke; Tao Ding; Wenjing Zhao; Wai Ming Cheng; Zhanhao Luo; Qilang He; Wanyi Zeng; Jing Yu; Na Jiao; Yanmin Liu; Bin Zheng; Lei Dai; Min Zhi; Xiaojian Wu; Christian Jobin; Ping Lan
Journal:  Microbiome       Date:  2021-11-23       Impact factor: 14.650

5.  Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity.

Authors:  Guido J Bakker; Abraham S Meijnikman; Torsten P Scheithauer; Mark Davids; Ömrüm Aydin; Thomas C C Boerlage; L Maurits de Brauw; Arnold W van de Laar; Victor E Gerdes; Albert K Groen; Daniël H van Raalte; Hilde Herrema; Max Nieuwdorp
Journal:  Obes Sci Pract       Date:  2021-08-13

6.  Microbial DNA Enrichment Promotes Adrenomedullary Inflammation, Catecholamine Secretion, and Hypertension in Obese Mice.

Authors:  Hong Gao; Zhongmou Jin; Kechun Tang; Yudong Ji; Jorge Suarez; Jorge A Suarez; Karina Cunha E Rocha; Dinghong Zhang; Wolfgang H Dillmann; Sushil K Mahata; Wei Ying
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106

Review 7.  Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?

Authors:  Rima M Chakaroun; Lucas Massier; Peter Kovacs
Journal:  Nutrients       Date:  2020-04-14       Impact factor: 5.717

Review 8.  The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders.

Authors:  Maafi R Islam; Subha Arthur; Jennifer Haynes; Molly R Butts; Niraj Nepal; Uma Sundaram
Journal:  Nutrients       Date:  2022-01-31       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.